Drug Profile
Ismomultin alfa
Alternative Names: ORG 39141Latest Information Update: 16 Mar 2005
Price :
$50
*
At a glance
- Originator Organon
- Class Antirheumatics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rheumatoid arthritis
Most Recent Events
- 31 Dec 2004 Discontinued - Phase-II for Rheumatoid arthritis in USA (unspecified route)
- 23 Jul 2002 Phase-II clinical trials in Rheumatoid arthritis in USA (unspecified route)